The Effect of Sacubitril-Valsartan in Heart Failure Patients With Mid-Range and Preserved Ejection Fraction: A Meta-Analysis
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine
Reference26 articles.
1. Epidemiology and clinical course of heart failure with preserved ejection fraction;Lam;Eur J Heart Fail,2011
2. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF);Rickenbacher;Eur J Heart Fail,2017
3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
4. Developing therapies for heart failure with preserved ejection fraction: current state and future directions;Butler;JACC Heart Fail,2014
5. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle;Zile;N Engl J Med,2004
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eligibility of sodium-glucose cotransporter-2 inhibitors in heart failure with preserved ejection fraction: Insights from the Colombian heart failure registry (RECOLFACA);IJC Heart & Vasculature;2024-08
2. Patient Focus: Should you take sacubitril/valsartan if you have heart failure with an ejection fraction >40% and get low blood pressure? An explanation of “Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial”;Journal of Cardiac Failure;2024-05
3. The Safety and Efficacy of the Early Use of Sacubitril/Valsartan After Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials;Cureus;2024-02-07
4. Documento de consenso sobre el uso de sacubitrilo/valsartán en pacientes con insuficiencia cardiaca: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) de la Sociedad Interamericana de Cardiología (SIAC);Archivos de Cardiología de México;2023-11-03
5. Efficacy of sacubitril / valsartan in the treatment of chronic heart failure: an updated review;Meditsinskiy sovet = Medical Council;2023-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3